GXI Gerresheimer AG

EQS-News: Gerresheimer: EcoVadis Gold with further improved score

EQS-News: Gerresheimer AG / Key word(s): ESG
Gerresheimer: EcoVadis Gold with further improved score

16.09.2024 / 13:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Gerresheimer: EcoVadis Gold with further improved score

  • Gerresheimer among the top 3 % of all rated companies
  • Overall result increased to 76/100 points
  • Award underlines consistent implementation of the sustainability strategy

Düsseldorf, September 16, 2024 - Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has once again been awarded Gold by the sustainability rating provider EcoVadis. EcoVadis evaluates the management systems of companies in the categories of environment, labor and human rights, ethics and sustainable procurement. More than 130,000 companies worldwide have their sustainability performance assessed by EcoVadis. In 2024, Gerresheimer was again among the top 3% of all companies assessed by EcoVadis and among the top 1% in the industry. The rating result rose to 76 out of 100 points (2023: 74 out of 100 points). The rating result underlines Gerresheimer's progress in implementing its sustainability strategy. Sustainability is an integral part of Gerresheimer's corporate strategy formula g.

 "Our sustainability standards are high, and our goals are ambitious," explains Dietmar Siemssen, CEO of Gerresheimer AG. "Independent external assessments such as the one from EcoVadis confirm the maturity of our management system, which we use to consistently embed sustainability in our company. EcoVadis Gold is both an award and an incentive for us to continuously improve our sustainability performance."

Gerresheimer among the top 3% in the industry

Since 2011, Gerresheimer has been using EcoVadis to have its sustainability management in the four different dimensions assessed by an independent body. In 2022, Gerresheimer achieved gold status for the first time with 68 out of 100 points. In 2024, the company was once again able to increase its score to 76 out of 100 points. Gerresheimer is thus not only among the top 3% of all companies assessed by EcoVadis, but also among the top 1% in the industry.

Comprehensive evaluation catalog and detailed monitoring
EcoVadis' extensive Corporate Social Responsibility (CSR) assessment catalog is based on internationally recognized standards such as the UN Global Compact, the conventions of the International Labour Organization (ILO), the standards of the Global Reporting Initiative (GRI), the ISO 26000 standard, the CERES principles and the UN Guiding Principles on Business and Human Rights. The EcoVadis rating thus covers a wide range of information on the performance of companies in the areas of the environment, labor and human rights, ethics and sustainable procurement, taking into account industry-specific characteristics. As part of its 360° monitoring, EcoVadis also includes a wide range of publicly available information such as news, NGO reports, government publications and court rulings in its assessment.

Transparency and independent external evaluation

Gerresheimer aims to provide transparent, well-founded and comparable information on the targets, measures and results of its sustainability activities in accordance with best practice standards.

Gerresheimer publishes an annual and discloses relevant data on the EcoVadis platform and as part of the CDP rating. In addition, MSCI, Sustainalytics and ISS assess the company's sustainability performance. An overview of Gerresheimer's external sustainability ratings can be .

 

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, dropper bottles, other bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. With 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. With around 12,000 employees, the company generated revenues of around €2bn in 2023. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).  
 


Contact Gerresheimer AG

Media  
Jutta Lorberg
Head of Corporate Communication
T 4
Marion Stolzenwald
Senior Manager Corporate Communication
T

Investor Relations
 
Guido Pickert
Vice President Investor Relations
T 45

 
Thomas Rosenke
Senior Manager Investor Relations
T: 7


16.09.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Duesseldorf
Germany
Phone: +49-(0)211/61 81-00
Fax: +49-(0)211/61 81-121
E-mail:
Internet:
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1988901

 
End of News EQS News Service

1988901  16.09.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1988901&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
16/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Gerresheimer AG

Gerresheimer AG: 1 director

A director at Gerresheimer AG bought 1,000 shares at 74.994EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

 PRESS RELEASE

EQS-News: Solarstrom für Gerresheimer Standort in Momignies, Belgien

EQS-News: Gerresheimer AG / Schlagwort(e): ESG Solarstrom für Gerresheimer Standort in Momignies, Belgien 14.10.2024 / 11:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Solarstrom für Gerresheimer Standort in Momignies, Belgien 2,3 MWp Photovoltaik-Dachanlage auf Produktionsgebäude Gerresheimer baut Ökostromanteil bei Energieversorgung aus Ziel bis 2030: 100 % Strom aus erneuerbaren Quellen Düsseldorf/ Momignies, 14. Oktober 2024. Gerresheimer, innovativer System- und Lösungsanbieter und globaler Partner für die Pharma-, Biotec...

 PRESS RELEASE

EQS-News: Solar power for Gerresheimer site in Momignies, Belgium

EQS-News: Gerresheimer AG / Key word(s): ESG Solar power for Gerresheimer site in Momignies, Belgium 14.10.2024 / 11:00 CET/CEST The issuer is solely responsible for the content of this announcement. Solar power for Gerresheimer site in Momignies, Belgium 2.3 MWp rooftop photovoltaic system on production building Gerresheimer increases share of green electricity in its energy supply Goal for 2030: 100% electricity from renewable sources Duesseldorf/Momignies, October 14, 2024. Gerresheimer, an innovative system and solution partner and a global partner for the pharma, ...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 10/01/2024

Like Astérix in the album of the same name, Michel Barnier has a cauldron to fill. Two measures to manage this have “leaked” in the press in the last few days: a reduction in the CIR research tax credit and an exceptional tax increase on large companies. We measured the sensitivity to these two measures of the 90 and 80 companies most concerned in our coverage universe. 20 companies have a CIR >5% of their EBIT and 22 companies would see their EPS fall by more than 5% due to the addit...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 01/10/2024

Comme Astérix dans l’album éponyme, Barnier a un chaudron à remplir. Deux mesures pour y parvenir ont « fuité » ces derniers jours dans la presse : rabotage du CIR (Crédit d’impôt Recherche) et hausse « exceptionnelle » de l’impôt des sociétés sur les grands groupes. Nous avons mesuré la sensibilité des 90 et 80 sociétés les plus concernées dans notre univers de couverture à ces deux mesures. 20 sociétés ont un CIR > 5% de leur EBIT et 22 sociétés verraient leurs BPA baisser de plus d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch